Skip to content
sellWeak cluster of 210b5-1 plan

Jay David Caplan sold $82k of GUTS

President, Chief Product Off. at FRACTYL HEALTH, INC.. 43,818 shares at an average of $1.88, traded Jan 30, 2025, filed Feb 3, 2025.

Warning score
12
Value
$82k
43,818 shares
Holdings after
153,544
-25% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    President
    +20
  • Trade size
    $82k at market
    +9
  • Share of holdings sold
    Sold 25% of holdings
    +10
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -6.5%, 3m -4.1%, 6m +9.4%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

GUTSOct 12, 2026 · close 4.41
Since filing Feb 3, 2025: -78.4%SPY +32.7% · excess -111.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-25-012530, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 30, 2025MOption exercise
Common Stock10b5-1
+21,472$1.70$37k175,016Feb 3, 2025
Jan 30, 2025SOpen-market sale
Common Stock10b5-1
-21,472$1.95$42k153,544Feb 3, 2025
Jan 31, 2025MOption exercise
Common Stock10b5-1
+22,346$1.70$38k175,890Feb 3, 2025
Jan 31, 2025SOpen-market sale
Common Stock10b5-1
-22,346$1.81$40k153,544Feb 3, 2025
Jan 30, 2025MOption exercise
Stock Optionderivative10b5-1
-21,472$0.00$040,270Feb 3, 2025
Jan 31, 2025MOption exercise
Stock Optionderivative10b5-1
-22,346$0.00$017,924Feb 3, 2025

Related signals

Other insiders at FRACTYL HEALTH, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
GUTSbuy
FRACTYL HEALTH, INC.
William Bradley
director
$40k
64,516 shares
+76%
48Moderate
GUTSbuy 5
FRACTYL HEALTH, INC.
Ajay Royan
director
$20k
23,000 shares
+128%
55Moderate
GUTSbuy 5
FRACTYL HEALTH, INC.
William Bradley
director
$50k
68,493 shares
+425%
48Moderate
GUTSbuy 5
FRACTYL HEALTH, INC.
Harith Rajagopalan
Chief Executive Officer
$18k
25,000 shares
+5%
51Moderate
GUTSbuy 5
FRACTYL HEALTH, INC.
Ian Sheffield
director
$26k
35,000 shares
-
53Moderate
GUTSbuy 5
FRACTYL HEALTH, INC.
Weber Lara Smith
Chief Financial Officer
$14k
20,000 shares
-
33Weak
GUTSbuy
FRACTYL HEALTH, INC.
Harith Rajagopalan
Chief Executive Officer
$20k
10,416 shares
+2%
44Moderate
GUTSbuy 5
FRACTYL HEALTH, INC.
Kelly Ann Barnes
director
$40k
31,000 shares
-
38Weak
GUTSbuy 5
FRACTYL HEALTH, INC.
Ajay Royan
director, owner
$23k
17,901 shares
-
38Weak
GUTSbuy 5
FRACTYL HEALTH, INC.
William Bradley
director
$20k
16,129 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jay David Caplan sold $82k of GUTS | InsiderTell